Citation: Jp. Luo et al., THE ROLES OF DEPOT INJECTION SITES AND PROXIMAL LYMPH-NODES IN THE PRESYSTEMIC ABSORPTION OF FLUPHENAZINE DECANOATE AND FLUPHENAZINE - EX-VIVO EXPERIMENTS IN RATS, Pharmaceutical research, 15(9), 1998, pp. 1485-1489
Citation: Jh. Yan et al., STEREOSELECTIVE AND SIMULTANEOUS MEASUREMENT OF CIS-ISOMER AND TRANS-ISOMER OF DOXEPIN AND N-DESMETHYLDOXEPIN IN PLASMA OR URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 691(1), 1997, pp. 131-138
Citation: Jp. Luo et al., SENSITIVE METHOD FOR THE SIMULTANEOUS MEASUREMENT OF FLUPHENAZINE DECANOATE AND FLUPHENAZINE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH COULOMETRIC DETECTION, Journal of chromatography B. Biomedical sciences and applications, 688(2), 1997, pp. 303-308
Citation: Jp. Luo et al., STUDIES ON THE MECHANISM OF ABSORPTION OF DEPOT NEUROLEPTICS - FLUPHENAZINE DECANOATE IN SESAME OIL, Pharmaceutical research, 14(8), 1997, pp. 1079-1084
Citation: Jh. Yan et al., STEREOSELECTIVE IN-VIVO AND IN-VITRO STUDIES ON THE METABOLISM OF DOXEPIN AND N-DESMETHYLDOXEPIN, Xenobiotica, 27(12), 1997, pp. 1245-1257
Authors:
HUBBARD JW
NORDSTROM ST
SMITH CP
BROOKS KM
LAWSRICKER L
ZHOU L
VARGAS HM
Citation: Jw. Hubbard et al., ALPHA-ADRENERGIC ACTIVITY AND CARDIOVASCULAR EFFECTS OF BESIPIRDINE HCL (HP-749) AND METABOLITE P7480 IN-VITRO AND IN THE CONSCIOUS RAT ANDDOG, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 337-346
Citation: Kk. Midha et al., INDIVIDUAL AND AVERAGE BIOEQUIVALENCE OF HIGHLY VARIABLE DRUGS AND DRUG PRODUCTS, Journal of pharmaceutical sciences, 86(11), 1997, pp. 1193-1197
Citation: Kk. Midha et al., RETROSPECTIVE EVALUATION OF RELATIVE EXTENT OF ABSORPTION BY THE USE OF PARTIAL AREAS UNDER PLASMA-CONCENTRATION VERSUS TIME CURVES IN BIOEQUIVALENCE STUDIES ON CONVENTIONAL RELEASE PRODUCTS, European journal of pharmaceutical sciences, 4(6), 1996, pp. 381-384
Authors:
MIDHA KK
HUBBARD JW
RAWSON MJ
MCKAY G
SCHWEDE R
Citation: Kk. Midha et al., THE ROLES OF STEREOCHEMISTRY AND PARTIAL AREAS IN A PARALLEL DESIGN STUDY TO ASSESS THE BIOEQUIVALENCE OF 2 FORMULATIONS OF HYDROXYCHLOROQUINE - A DRUG WITH A VERY LONG HALF-LIFE, European journal of pharmaceutical sciences, 4(5), 1996, pp. 283-292
Citation: Kk. Midha et al., THE IMPACT OF STEREOISOMERISM IN A BIOEQUIVALENCE STUDY ON 2 FORMULATIONS OF DOXEPIN, European journal of pharmaceutical sciences, 4(3), 1996, pp. 133-138
Citation: Gq. Zhang et al., APPLICATION OF ELECTROSPRAY MASS-SPECTROMETRY IN THE IDENTIFICATION OF INTACT GLUCURONIDE AND SULFATE CONJUGATES OF CLOZAPINE IN RAT, Xenobiotica, 26(5), 1996, pp. 541-550
Authors:
GOFF DC
MIDHA KK
SARIDSEGAL O
HUBBARD JW
AMICO E
Citation: Dc. Goff et al., A PLACEBO-CONTROLLED TRIAL OF FLUOXETINE ADDED TO NEUROLEPTIC IN PATIENTS WITH SCHIZOPHRENIA, Psychopharmacology, 117(4), 1995, pp. 417-423
Citation: Y. Huang et al., THE ROLE OF THE LYMPHATIC-SYSTEM IN THE PRESYSTEMIC ABSORPTION OF FLUPHENAZINE AFTER INTRAMUSCULAR ADMINISTRATION OF FLUPHENAZINE DECANOATEIN RATS, European journal of pharmaceutical sciences, 3(1), 1995, pp. 15-20
Authors:
HADAD S
HUBBARD JW
MCKAY G
HAWES EM
SHRIKHANDE S
MIDHA KK
Citation: S. Hadad et al., EVIDENCE FOR THE LACK OF A HUMAN METABOLIC ISOTOPE EFFECT OF A DEUTERIUM ANALOG OF FLUPHENAZINE, Pharmaceutical research, 12(9), 1995, pp. 1388-1390
Authors:
HUBBARD JW
HSU RS
GRIFFITHS L
NATARAJAN C
DEAN R
DILEO EM
HINTZE TH
Citation: Jw. Hubbard et al., THE PHARMACOKINETICS AND CARDIOVASCULAR PHARMACODYNAMICS OF HP-749 (BESIPIRDINE HCL) AND METABOLITE P86-7480 IN THE CONSCIOUS MONKEY, Journal of clinical pharmacology, 35(7), 1995, pp. 688-696
Authors:
SAINATI SM
HUBBARD JW
CHI E
GRASING K
BRECHER MB
Citation: Sm. Sainati et al., SAFETY, TOLERABILITY, AND EFFECT OF FOOD ON THE PHARMACOKINETICS OF ILOPERIDONE (HP-873), A POTENTIAL ATYPICAL ANTIPSYCHOTIC, Journal of clinical pharmacology, 35(7), 1995, pp. 713-720
Authors:
MIDHA KK
HUBBARD JW
MCKAY G
RAWSON M
SCHWEDE R
Citation: Kk. Midha et al., STEREOSELECTIVITY IN BIOEQUIVALENCE STUDIES OF NORTRIPTYLINE, Journal of pharmaceutical sciences, 84(10), 1995, pp. 1265-1266
Authors:
MIDHA KK
HUBBARD JW
MARDER SR
MARSHALL BD
VANPUTTEN T
Citation: Kk. Midha et al., IMPACT OF CLINICAL PHARMACOKINETICS ON NEUROLEPTIC THERAPY IN PATIENTS WITH SCHIZOPHRENIA, Journal of psychiatry & neuroscience, 19(4), 1994, pp. 254-264
Citation: Kk. Midha et al., THE APPLICATION OF PARTIAL AREAS IN ASSESSMENT OF RATE AND EXTENT OF ABSORPTION IN BIOEQUIVALENCE STUDIES OF CONVENTIONAL RELEASE PRODUCTS - EXPERIMENTAL-EVIDENCE, European journal of pharmaceutical sciences, 2(5-6), 1994, pp. 351-363
Citation: G. Lin et al., DECOMPOSITION OF CLOZAPINE N-OXIDE IN THE QUALITATIVE AND QUANTITATIVE-ANALYSIS OF CLOZAPINE AND ITS METABOLITES, Journal of pharmaceutical sciences, 83(10), 1994, pp. 1412-1417
Authors:
MIDHA KK
MARDER SR
JAWORSKI TJ
MCKAY G
HUBBARD JW
HAWES EM
VANPUTTEN T
WIRSHING WC
ARAVAGIRI M
Citation: Kk. Midha et al., CLINICAL PERSPECTIVES OF SOME NEUROLEPTICS THROUGH DEVELOPMENT AND APPLICATION OF THEIR ASSAYS, Therapeutic drug monitoring, 15(3), 1993, pp. 179-189
Authors:
WANG J
ZHAO G
SHEN WQ
OCHOA M
MOORE D
HUBBARD JW
HINTZE TH
Citation: J. Wang et al., EFFECTS OF AN ORALLY-ACTIVE NO-RELEASING AGENT, CAS-936, AND ITS ACTIVE METABOLITE, 3754, ON CARDIAC AND CORONARY DYNAMICS IN NORMAL CONSCIOUS DOGS AND AFTER PACING-INDUCED HEART-FAILURE, Journal of cardiovascular pharmacology, 22, 1993, pp. 190000051-190000058